TripleMap is an enterprise knowledge discovery & collaboration platform which can be securely deployed within an organization's firewall or hosted in the cloud. TripleMap allows users such as biologists, chemists, patent attorneys, market analysts, and clinical trial specialists to search through and analyze the entities and associations between entities in the secure, massive interconnected GEM Semantic Data Core which is continuously aggregated from internal and external sources. TripleMap represents everything in its semantic data core as "master entities" that integrate all information for any given entity (e.g. protein, gene, compound, clinical trial, disease) including names, synonyms, symbols, meta-data properties, and associations to other entities. By searching for, and saving sets of entities, users build, share and, analyze "dynamic knowledge maps" of entities and their associations. These knowledge maps give users a "bird's eye view" of patterns of interconnection between entities of interest, are used to continuously scan for novel information as it becomes available and allow users to find other users creating similar maps, thereby enabling collaborative knowledge exchange.

Dr. Bouton 

 

Dr. Bouton received his BA in Neuroscience (Magna Cum Laude) from Amherst College in 1996 and his Ph.D in Molecular Neurobiology from Johns Hopkins University in 2001. Between 2001 and 2004 Dr. Bouton worked as a computational biologist at LION Bioscience Research Inc. and Aveo Pharmaceuticals, leading the microarray data analysis functions at both companies. In 2004 he accepted the position of Head of Integrative Data Mining for Pfizer and led a group of Ph.D. level scientists conducting research in the areas of computational biology, systems biology, knowledge engineering, software development, machine learning and large-scale 'omics data analysis. While at Pfizer, Dr. Bouton conceived of and implemented an organization-wide wiki called Pfizerpedia for which he won the prestigious 2007 William E. Upjohn Award in Innovation. In 2008 Dr. Bouton assumed the position of CEO at Entagen (http://www.entagen.com), a biotechnology company that provides computational research, analysis and custom software development services for biomedical organizations. Dr. Bouton is an author on over a dozen scientific papers and book chapters and his work has been covered in a number of industry news articles.